Speaker

Dr. Masakazu Toi graduated in 1982 from Hiroshima University School of Medicine with his Medical Doctorate and in 1988 with his Ph.D.

Dr. Toi studied on molecular biology particularly hormone resistance and tumour angiogenesis at the Institute of Molecular Medicine of Oxford University, UK from 1990 to 1992. He was appointed to the Department of Clinical Oncology, John-Radcliffe Hospital of Oxford University as an academic visitor (Prof. Adrian L Harris).

From 1992 to 2007, Dr. Toi worked for Tokyo Metropolitan Cancer and Infectious Disease Center, a high-volume center of Tokyo Metropolitan Government Japan. He was appointed to a director of Surgery and to a director of Clinical Trial Department. In 2000, he studied at Department of Breast Medical Oncology, Dana-Farber Cancer Institute of Harvard University as a Yamagiwa-Yoshida fellow, UICC (Prof. Eric Winer).

Since 2007 Dr. Toi has been appointed to Professor of Breast Surgery at the Graduate School of Medicine, Kyoto University, Japan and Director of the Breast Cancer Team, Kyoto University Hospital.

He was appointed to the Deputy Director of the Society-Academia Collaboration for Innovation of Kyoto University from 2016 to 2018. He was appointed to the Director of Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital from April, 2023.

Dr. Toi has been involved many clinical trials of new therapy development and new diagnostics development especially for breast cancer. He contributed to over 800 original papers, reviews, and books. His current interests in laboratories are breast cancer tumor-immune microenvironment (TIME), molecular imaging of the TIME, association between genomics and TIME and the significance of TIME in treatment, screening and prevention.